CCN2 and metabolic dysfunction-associated steatohepatitis: In NASH patients, HSCs have been shown to express high levels of the IL-13 receptor, and IL-13 was shown to induce TGFβ and connective tissue growth factor (CTGF, which is encoded by Ccn2) production in HSCs in vitro [43,44].